PUBLISHER: Allied Market Research | PRODUCT CODE: 1239489
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239489
The intrapartum monitoring devices market valued for $826.00 million in 2021 and is estimated to reach $1,624.43 million by 2031, exhibiting a CAGR of 7% from 2022 to 2031.
Intrapartum monitoring devices are fetal monitoring devices used for keeping a check on the uterine activity and the heart rate patterns of the fetus during an ongoing labor. Implementation of intrapartum monitoring device reduces the risks and complications to a certain extent during childbirth. These risks include cerebral palsy, brain damage, newborn seizures leading to fetal death during childbirth. These devices help in determining the health condition and several avoidable adverse effects related to childbirth and pregnancy such as acquired infections, hypertension and heavy bleeding. The developments in the field of intrapartum monitoring devices have a significant impact on maternal care, and fetal progression and health monitoring. Intensive fetal monitoring using these devices with the help of fetal EKG leads and intrauterine pressure sensing transducers, increase fetal care significantly. Furthermore, fetal monitoring data when used in integration with other monitor aids such as scalp pH increases the interoperability and importance in decision making processes, making them clinical in simple and complicated labor situations.
The growth of the intrapartum monitoring devices market is driven by increase in government & non-government initiatives for maternal & fetal health across the world, rise in awareness and willingness to invest in development of fetal monitoring and increase in number of multiple pregnancy, and premature delivery cases. Moreover, rise in high birth rate in developing and developed countries, increase in prevalence of premature births resulting into various complications related to child birth, and fatalities involving preterm births are expected to notably contribute toward the market growth. For instance, according to the data by Centers for Disease Control & Prevention, in 2021, the preterm birth affected about 1 of every 10 infants born in the U.S. The preterm birth rate rose 4% in 2021, from 10.1% in 2020 to 10.5% in 2021. The rate of preterm birth among African-American women (14.8%) was about 50% higher than the rate of preterm birth among white or Hispanic women. Prominent players in the global intrapartum monitoring devices market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in intrapartum monitoring devices to strengthen their position in the market and sustain the competitive environment.
However, dearth of highly skilled professionals, high cost of equipment, lack of intervening guidelines, technological limitations for the monitoring devices restrict the market growth. Conversely, the emergence of portable & wireless technologies and untapped emerging economies are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The intrapartum monitoring devices market is segmented on the basis of product type, method, end user and region. On the basis of product type, the market is bifurcated into monitors and electrodes. On the basis of method, the market is classified into invasive and non-invasive. On the basis of end user, the market is classified into hospitals, maternity centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include: Cardinal Health, Inc., Cooper Companies Inc., General Electric Company, Huntleigh Healthcare Limited, Koninklijke Philips N.V., Laborie, MedGyn products, Inc., Mindchild Medical, Inc., Rocket Medical plc, Stalwart Meditech.